Dr. Reddy’s Laboratories Ltd. gets FDA approval for generic Allegra
Yahoo - Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) said on Thursday that it has received final approval from the Food and Drug Administration (FDA) for its generic version of allergy medication Allegra, and will begin commercial marketing immediately.
The stock is near its 52 week high but the downturn in the Indian market the last couple of days is clearly affecting the stock.
Fatal error: Call to undefined function similar_posts() in /home2/kyastyle/public_html/india/wp-content/themes/financial_nirvana/single.php on line 36